Patient advocacy allows ESMO to support and promote equal access to optimal cancer treatment and care
Previously known as 'ESMO Patient Seminars', these meetings fulfill one of ESMO's most important objectives – to disseminate knowledge to advocacy groups, cancer patient associations, caregivers, and the public.
Patient Advocates play a crucial role in supporting and informing Cancer patients and caregivers and in providing valuable input into healthcare decision-making processes. In this setting, education of patient advocates becomes critical to both ensure that patients are provided with accurate information and that their input into healthcare decision-making processes is relevant.
Since ESMO2016, the ESMO Patient Advocacy Track has been fully integrated in the Congress programme, enabling patient advocates to attend the scientific sessions that are relevant to them as well as the patient advocacy sessions.
You can connect to the community joining the ESMO Patient Advocates Facebook Group.
ESMO 2020 Patient Advocacy Track
18 - 22 September, Madrid, Spain
Since ESMO2016, the ESMO Patient Advocacy Track (PAT) has been fully integrated in the Congress programme, enabling patient advocates to attend the scientific sessions that are relevant to them as well as the patient advocacy sessions.
The Patient Advocacy Track Sessions are designed by the ESMO Patient Advocates Working Group (PAWG) and represent an opportunity for all Congress delegates to learn, share and explore areas of collaboration while discussing topical issues for patients and survivors that directly impact cancer care and medical research.
The preliminary ESMO 2020 Patient Advocacy Track programme will be available here soon.
Apply here to present your project at the ESMO 2020 Patient Advocacy Track
The ESMO Patient Advocates Working Group (PAWG) seeks to identify up to 5 successful and inspiring projects lead by patient/ patient advocate organisations to be presented at the ESMO 2020 Patient Advocacy Track during the ESMO Annual Congress in Madrid, Spain.
The project representative will be invited to present the project and its impact on the cancer community, during a session of the PAT on Monday 21 September 2020. Each speaker will have a 15 minutes slot for her/his talk.
The application is structured in two phases:
Phase 1: Instructions for completing the application:
- Please fill out the application form available here. Please respect the text limit.
- Send your application form by email at the following email address: email@example.com
- Subject line: Application to present a patient advocate’s project at the ESMO 2020 PAT
- Deadline: 15 April 2020
The ESMO PAWG will select 15 projects for the second phase of the selection procedure. In this second phase the 15 applicants will be asked to submit a draft of their project presentation. Further details will be specified in the invitation to submit phase 2 applications. Applicants will have approximately four weeks to submit this second application.
The ESMO PAWG will then make a final selection of the five projects that will be invited to be showcased at the ESMO 2020 PAT.
- Deadline to submit phase 1 application: 15 April 2020
- Invitation to submit phase 2 application: first week of May 2020
- Deadline to submit phase 2 application: 31 May 2020
- Selection outcome: 3rd week of June 2020
ESMO 2019 Patient Advocacy Track
27 September - 1 October 2019, Barcelona, Spain
The 2019 Patient Advocates Track offered great educational sessions along with many opportunities to exchange best practices and network:
- 7 sessions and 33 faculty members
- Average of 350 attendees (with a few sessions attended by 800 delegates)
- More than 150 travel grants distributed
- 40 different countries represented, including Mexico, India, Canada and USA
- 7 industry supporters via educational grants
ESMO 2018 Patient Advocacy Track
19-23 October 2018, Munich, Germany
ESMO 2018 Patient Advocacy Track was very successful:
- 8 sessions and 33 faculty members
- Average of 260 attendees (with a few sessions resulting in overflow rooms)
- More than 160 travel grants distributed
- 38 different countries represented, including Canada, China, India, USA
- 8 industry supporters via educational grants
ESMO 2017 Patient Advocacy Track
8-12 September 2017, Madrid, Spain
ESMO 2017 Patient Advocacy Track registered the largest participation ever!
- 8 sessions and 35 faculty members
- Average of 250 attendees with peaks of over 1000 attendees for IO toxicities and 600 for PA reported outcomes
- 180 travel grants distributed
- 35 different countries represented, including USA, Brazil, India, Australia and Japan
- 7 industry supporters via educational grants
ESMO 2016 Patient Advocacy Track
7-11 October 2016, Copenhagen, Denmark
The ESMO 2016 Patient Advocacy Track had a new format, with advocacy-specific sessions taking place on the Friday (in parallel to industry-sponsored satellite symposia) and during lunch and early evening for the remainder of the congress.
This allowed patient advocates to attend sessions of interest to the advocacy community from other tracks such as Public Health and Health Economics, Supportive Care and Immunotherapy.
ESMO 2014 Patient Advocacy Track
27-28 September 2014, Madrid, Spain
For the first time at the ESMO 2014 Congress an entire track was dedicated to cancer patient advocates, representative of cancer leagues, healthcare professionals and industry representatives.
The event provided European patient organisations and bodies involved in patient care with an excellent networking opportunity and the possibility to discuss vital issues and challenges faced by cancer patients
The ESMO 2014 Patient Advocacy Track focused on Cancer Research, Treatment and Living, Capacity Building and Patient Adovacy. The track closed with a tribute to Selma Schimmel Founder of Vital Options® International, who passed away in May 2014 from a complication of ovarian cancer.
9th ESMO Patient Seminar
Held in Vienna, Austria, on Saturday 29 and Sunday 30 September 2012
8th ESMO Patient Seminar
Held in Milan, Italy, on Saturday 9 and Sunday 10 October 2010